Cytos Biotechnology Ltd: CYT003-QbG10 phase IIb data presented at EAACI 2010 in London, UK

(PresseBox) ( Schlieren, )
Cytos Biotechnology Ltd (SIX:CYTN) is pleased to inform you about two presentations at the 29th Congress of the European Academy of Allergy and Clinical Immunology in London, UK from June 5-9, 2010.

Prof. Klimek, the principal investigator of the study, will present 'Treatment with CYT003-QbG10, an allergenfree immunomodulator, reduces allergic symptoms in patients with rhinoconjunctivitis due to house dust mite allergy' on Sunday, June 6, 2010, 10.30 am - 12.00 pm.

Dr. Bachmann, CSO of Cyots Biotechnology, will present 'Bacteriophage coupled Fel d1 a novel immunotherapy agent for cat allergy' on Tuesday, June 8, 2010 at 10.30 am.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to